GBR 12783, a potent and selective inhibitor of dopamine uptake: Biochemical studies in vivo and ex vivo

https://doi.org/10.1016/0014-2999(86)90491-7Get rights and content

Abstract

The effects of GBR 12783, an aryl 1,4-dialk(en)ylpiperazine derivative, were studied on the in vivo and ex vivo neuronal uptake of dopamine (DA), norepinephrine (NE) and serotonin (5HT). The drug inhibited potently (IC50 = 1.8 nM) and competitively the [3H]DA uptake by rat striatal synaptosomes. It produced significant [14C]DA release only at much higher concentrations (in the micromolar range). Depending on the animal species (rat or mouse) and the experimental conditions, GBR 12783 was 18–90 times and 85–300 times less effective against NE and 5HT uptake respectively than against DA uptake. In synaptosomes preloaded with [3H]DA, GBR 12783 added to the superfusion medium prevented the (+)amphetamine-induced DA release. The total binding of [3H]GBR 12783 to a membranal fraction prepared from striatum was lower than the binding to a synaptosomal fraction, suggesting its entry in synaptosomes. In addition, the concentration-dependent release of [3H]DA produced by GBR 12783 from a striatal vesicular fraction may account for the synaptosomal DA release promoted by micromolar concentrations of the drug. In ex vivo experiments, the ID50 for DA uptake inhibition (30 min after i.p. administration) was 8.1 mg/kg. After a dose of 10 mg/kg i.p., the striatal DA uptake inhibition occurred quickly (< 10 min) and was long-lasting (> 5 h). The specificity of the drug for the DA uptake relative to NE and 5HT uptakes was also seen after i.p. administration of GBR 12783.

References (26)

  • A.J. Azzaro et al.

    The importance of neuronal uptake of amines for amphetamine-induced release of [3H]norepinephrine from isolated brain tissue

    J. Pharmacol. Exp. Ther.

    (1974)
  • Bonnet, J.-J., I. Dubuc and J. Costentin, Effects of antidepressant d drugs on uptake and storage of [3H]dopamine by r...
  • C.D.J. De Langen et al.

    Effects of psychotropic drugs in the distribution of [3H]dopamine into compartments of rat striatal synaptosomes and on subsequent depolarization- induced [3H]dopamine release

    Naunyn-Schmiedeb. Arch. Pharmacol.

    (1980)
  • Cited by (109)

    • Dopaminergic mechanisms underlying the expression of antipsychotic-induced dopamine supersensitivity in rats

      2021, Neuropharmacology
      Citation Excerpt :

      In Experiments 1–3, the different vehicles used produced similar locomotor responses and were pooled to form one vehicle control group. We assessed whether selectively blocking dopamine reuptake with GBR12783 (Bonnet and Costentin, 1986) [0, 5 or 10 mg/kg (Le Pen et al., 1996)] produces a supersensitive psychomotor response in haloperidol-treated rats. For comparison, we also assessed effects of the monoamine reuptake blocker cocaine (Rothman et al., 2001) [0, 2.5 or 10 mg/kg (Kosten, 1997)] and the D1/D2/monoamine receptor agonist apomorphine (Millan et al., 2002) [0, 0.25 or 0.5 mg/kg (Geyer et al., 1987; Barros et al., 1989)].

    • The role of N-glycosylation in function and surface trafficking of the human dopamine transporter

      2004, Journal of Biological Chemistry
      Citation Excerpt :

      The cell line for DAT expression was the same, HEK-293, and there should be no difference between the stable transfection used here and the transient transfection applied by Torres et al. (11). We found dopamine uptake to be linear with time up to 2 min in wild type and up to 8 min in the mutants, and it is known that uptake kinetics are not exactly the same when measured in the linear phase (short time) or at plateau (longer time) (20). Torres et al. (11) measured uptake for 5 min.

    View all citing articles on Scopus
    View full text